Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Teledyne Technologies raised its full-year 2026 adjusted profit forecast and posted quarterly results that exceeded Wall Street estimates, citing robust demand across digital imaging, instrumentation, and aerospace and defense businesses. The Thousand Oaks-based firm highlighted contributions from recent acquisitions and pronounced organic growth i…
Moody’s reported stronger first-quarter results with profit rising to $661 million, supported by growth in its analytics subscription business and a record quarter for its investor services ratings unit. The company also raised its full-year adjusted earnings per share forecast, even as its stock has declined year-to-date.
JPMorgan’s Oil & Gas team warns that several European airports and airlines face heightened risk this summer due to constrained jet fuel supplies. With Europe importing a significant share of its jet fuel from the Middle East and inventories already low, the bank says shortages could emerge as early as June under certain replacement scenarios, putt…
Shares of Willow Lane Acquisition Corp. (NASDAQ:WLAC) climbed 9% after Boost Run, the private company slated to merge with Willow Lane, reached a $1.44 billion purchase agreement with Dell Technologies for hardware, software and financing support designed to scale enterprise AI capacity across Boost Run’s colocation sites. The planned combination w…
Lebanese and Israeli envoys are due to meet in Washington for a second ambassadorial session in two weeks as a 10-day U.S.-brokered ceasefire approaches its expiry. Lebanon is seeking an extension of the agreement and wants the pause in hostilities to be the precondition for expanded talks aimed at withdrawal of Israeli forces, return of detainees …
AST SpaceMobile received Federal Communications Commission commercial authorization to provide direct-to-device cellular broadband from space across the United States, a decision that lifted its shares pre-market. The approval permits a non-geostationary orbit constellation of up to 248 satellites and the coordinated use of 700 MHz and 800 MHz low-…
Boeing reported a much smaller first-quarter net loss than analysts anticipated, signaling progress in its operational recovery. The planemaker posted a $7 million loss for the quarter and a core loss per share of $0.20, well ahead of the $0.83-per-share shortfall Wall Street had expected. Strong jet deliveries and an uptick in defense earnings con…
Alibaba Group shares rose about 2% after a report said the company is negotiating to invest in AI startup DeepSeek alongside Tencent. DeepSeek, owned by hedge fund High-Flyer Capital Management, recently began fundraising for the first time and has seen its valuation target move higher amid investor interest. Discussions are ongoing and both the va…
BridgeBio Pharma announced the approval and issuance of restricted stock unit grants to 33 new employees totaling 67,247 shares, as inducements for employment under Nasdaq Listing Rule 5635(c)(4), with vesting schedules tied to continued employment. The grants aim to attract and retain talent to support the company's focus on developing medicines f…
Stock Yards Bancorp, Inc. (NASDAQ: SYBT) reported strong first quarter 2026 earnings of $36.6 million, or $1.24 per diluted share, representing growth from $33.3 million, or $1.13 per diluted share, in Q1 2025. The performance was driven by solid loan growth across markets, net interest margin expansion, and record wealth management revenue. The co…
Arq, Inc., a U.S. producer of activated carbon and environmentally efficient carbon products, announced it will release its first quarter 2026 financial results on May 6, followed by an earnings conference call on May 7. The company is the only vertically integrated activated carbon producer in North America, focusing on environmental technology so…
Zevra Therapeutics, a commercial-stage biopharmaceutical company specializing in rare disease therapies, announced it will release its corporate and financial results for Q1 2026 on May 6, 2026, after market close. The company will also host a conference call and webcast to discuss these results. Zevra continues to focus on expanding its geographic…
ASML Holding N.V. disclosed the results of its 2026 AGM, approving the 2025 financial statements, a final dividend payment leading to a total dividend of €7.50 per ordinary share for 2025, reappointments and appointments to the Board of Management and Supervisory Board, and authorizations for share issuance and repurchase programs. The AGM also cov…
Viomi Technology Co., Ltd, a NASDAQ-listed Chinese company specializing in AI-powered home water purification solutions, announced the filing of its 2025 annual report (Form 20-F) with the U.S. Securities and Exchange Commission. The report highlights Viomi's innovative 'Equipment + Consumables' business model, advanced technology in intelligent wa…
WEBUY GLOBAL LTD. announced a record-breaking performance at the NATAS Fair March 2026, generating over US$3.34 million in travel bookings within three days, a 27% increase year-over-year. The success was driven by the company's proprietary AI-assisted sales tool, enhancing customer consultations, demand analysis, and sales conversion in a highly c…
RenX Enterprises Corp. expects to report first quarter 2026 revenue of over $3.5 million, marking sequential growth compared to Q4 2025. The growth is driven by stronger material sales at its Myakka City organic processing facility and increased logistics revenue from its Zimmer Equipment Inc. transportation operations. The company is progressing w…
TG Therapeutics has announced data presentations at the American Academy of Neurology 2026 Annual Meeting highlighting the clinical and real-world effectiveness, safety, and optimized dosing of BRIUMVI (ublituximab-xiiy) for relapsing multiple sclerosis (RMS). These data include findings from the Phase 4 ENABLE observational study and the ENHANCE d…
Repligen Corporation will release its financial results for the first quarter of 2026 on May 5, followed by a conference call to discuss business updates and quarterly performance. The company specializes in bioprocessing technologies and serves biopharmaceutical developers and CDMOs worldwide.
BullFrog AI Holdings, a Nasdaq-listed AI-driven biomedical technology company, announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement through sales under its at-the-market and equity-line-of-credit facilities. The company highlighted a recent commercial agreement with a top 5 global pharmaceutical firm, extendin…
CervoMed presented new placebo-controlled MRI analyses at the 2026 AAN Annual Meeting demonstrating that neflamapimod increased basal forebrain volume and enhanced functional connectivity in patients with Dementia with Lewy Bodies (DLB). The data strengthens evidence that neflamapimod may target the underlying disease process in DLB, a progressive …
Palantir Technologies announced a $300 million Blanket Purchase Agreement with the U.S. Department of Agriculture to provide operational software supporting USDA’s National Farm Security Action Plan. The deal builds on the company’s work powering the Landmark platform and aims to streamline service delivery, accelerate payments, and consolidate leg…
Barclays revised ratings across its semiconductor coverage before first-quarter earnings, moving three stocks to Overweight and lowering one to Equal Weight while reinstating another at Underweight. The firm highlighted hard disk drives and radio frequency chipmakers as the most attractive pockets of value within a market where fundamentals are wid…
Best Buy announced that Jason Bonfig will succeed Corie Barry as chief executive officer on October 31. The move comes as the electronics retailer works to restore growth following a sustained slowdown in demand for consumer electronics driven by household cost pressures. Barry, who has served as CEO since 2019, will remain with the company as a st…
Alterity Therapeutics presented new analyses of its Phase 2 trial data for ATH434, demonstrating significant slowing of functional decline in patients with Multiple System Atrophy (MSA) using the novel MuSyCA composite scale. The data reinforce ATH434's potential as a disease-modifying treatment ahead of planned Phase 3 regulatory engagement.
CME Group reported stronger first-quarter adjusted profit driven by a surge in trading activity across interest-rate and equity index futures as market volatility prompted investors to hedge. Average daily volumes reached a record 36.2 million contracts, lifting clearing and transaction fees and supporting year-over-year profit growth.
